Deferiprone Patent Expiration
Deferiprone is Used for managing transfusional iron overload. It was first introduced by Chiesi Usa Inc
Deferiprone Patents
Given below is the list of patents protecting Deferiprone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ferriprox | US10780055 | Delayed release deferiprone tablets and methods of using the same | Oct 25, 2038 | Chiesi |
| Ferriprox | US10940115 | Delayed release deferiprone tablets and methods of using the same | Oct 25, 2038 | Chiesi |
| Ferriprox | US10940116 | Delayed release deferiprone tablets and methods of using the same | Oct 25, 2038 | Chiesi |
| Ferriprox | US11357731 | Delayed release deferiprone tablets and methods of using the same | Oct 25, 2038 | Chiesi |
| Ferriprox | US11458103 | Delayed release deferiprone tablets and methods of using the same | Oct 25, 2038 | Chiesi |
| Ferriprox | US11723874 | Delayed release deferiprone tablets and methods of using the same | Oct 25, 2038 | Chiesi |
| Ferriprox | US8703156 | Liquid formulation for deferiprone with palatable taste | Oct 26, 2029 | Chiesi |
| Ferriprox | US7049328 | Use for deferiprone |
Jun 28, 2021
(Expired) | Chiesi |
Deferiprone's Family Patents
Explore Our Curated Drug Screens
Deferiprone Generic API Manufacturers
Several generic applications have been filed for Deferiprone. The first generic version for Deferiprone was by Taro Pharmaceutical Industries Ltd and was approved on Feb 8, 2019. And the latest generic version is by Taro Pharmaceutical Industries Ltd and was approved on Nov 22, 2023.
Given below is the list of companies who have filed for Deferiprone generic, along with the locations of their manufacturing plants worldwide.
1. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Deferiprone. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet | Prescription | ORAL | AB | Mar 29, 2021 |
| 1GM
(reference standard) | tablet | Prescription | ORAL | AB | Feb 8, 2022 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
2. TARO
Taro Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Deferiprone. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG | tablet | Prescription | ORAL | AB | Feb 8, 2019 |
| 1GM | tablet | Prescription | ORAL | AB | Nov 22, 2023 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||